(Q35790886)

10 August 2017

1 reference

title

Application of Quillaja saponaria extracts as oral adjuvants for plant-made vaccines (English)

1 reference

10 August 2017

Quillaja saponaria

1 reference

Dwayne D Kirk

1

1 reference

10 August 2017

Rachel Rempel

series ordinal

2

1 reference

10 August 2017

Julia Pinkhasov

series ordinal

3

1 reference

10 August 2017

Amanda M Walmsley

series ordinal

4

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Expert Opinion on Biological Therapy

10 August 2017

1 reference

10 August 2017

4

1 reference

10 August 2017

6

1 reference

10 August 2017

947-958

1 reference

Plant cell factories and mucosal vaccines

10 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

A plant-based multicomponent vaccine protects mice from enteric diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

Passive immunization of mice pups through oral immunization of dams with a plant-derived vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

Expression of the B subunit of Escherichia coli heat-labile enterotoxin as a fusion protein in transgenic tomato.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

Production of a fusion protein consisting of the enterotoxigenic Escherichia coli heat-labile toxin B subunit and a tuberculosis antigen in Arabidopsis thaliana.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

Immune responses of mice to inactivated rabies vaccine administered orally: potentiation by Quillaja saponin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

Uptake and adjuvant activity of orally delivered saponin and ISCOM vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

ISCOMs and other saponin based adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

A mechanism for the hypocholesterolaemic activity of saponins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

LEGAL STATUS AND TOXICITY OF SAPONINS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

The effect of saponin, sterols and linoleic acid on the weight increase of growing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

Long-term toxicity study of quillaia extract in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.6.947

21 January 2018

Identifiers

DOI

10.1517/14712598.4.6.947

1 reference

10 August 2017

1 reference